← Open Payments lookup

DAVID KORMAN: Open Payments

NPI 1942204755 · CANTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,084 in 125 payments from 11 companies in 2025. Trend: 2023 $1,793 · 2024 $1,643 · 2025 $2,084

Food & beverage: $1,980Education: $104
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.23$388
ABBVIE INC.17$298
E.R. Squibb & Sons, L.L.C.18$258
Neurocrine BioSciences, Inc.15$257
Vanda Pharmaceuticals Inc.19$207
Otsuka America Pharmaceutical, Inc.7$181
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$146
Alkermes, Inc.6$110
Lundbeck LLC5$99
Axsome Therapeutics, Inc.6$98

Products named: VRAYLAR, REXULTI, COBENFY, INGREZZA, FANAPT, AUSTEDO XR, CAPLYTA, ARISTADA.

Industry payments across TX — which companies pay providers there.